Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Small Molecule Bda-366 As a Bcl2-BH4 Antagonist for Multiple Myeloma Therapy

Jiusheng Deng, PhD, Dongkyoo Park, PhD, Mengchang Wang, Qiaoya Deng, Shannon Matulis, PhD, Lawrence H. Boise, PhD, Xingming Deng, MD PhD

Blood (2015) 126 (23): 2049.

https://doi.org/10.1182/blood.V126.23.2049.2049

Published: 2015

Journal Articles

Protein phosphatase 2A inactivates Bcl2's antiapoptotic function by dephosphorylation and up-regulation of Bcl2-p53 binding

Xingming Deng, Fengqin Gao, W. Stratford May

Blood (2009) 113 (2): 422–428.

https://doi.org/10.1182/blood-2008-06-165134

Published: 2009

Journal Articles

Protein Phosphatase 2A Inactivates Bcl2’s Antiapoptotic Function by Dephosphorylation and Up-Regulation of Bcl2-p53 Binding.

Xingming Deng, MD, Fengqin Gao, Tammy Flagg, W. Stratford May, M.D., Ph.D.

Blood (2006) 108 (11): 1436.

https://doi.org/10.1182/blood.V108.11.1436.1436

Published: 2006

Journal Articles

Bcl2 Flexible Loop Domain Positively and Negatively Regulates Survival Function through Direct Interaction with p53.

Xingming Deng, MD, Fengqin Gao, Tammy Flagg, Jessica Anderson, W. Stratford May, MD, Ph.D

Blood (2005) 106 (11): 2623.

https://doi.org/10.1182/blood.V106.11.2623.2623

Published: 2005

Journal Articles

Mechanisms of Apoptosis Induction by BH3 Inhibitor ABT-737 in AML.

Michael Andreeff, MD, PhD, Rooha Contractor, Peter P. Ruvolo, PhD, Xingming Deng, MD, PhD, Ismael Samudio, PhD, Yue-Xi Shi, Teresa McQueen, BS, Rui-Yu Wang, MD, PhD, Wendy Schober, Xiaoyang Ling, PhD, Frank C. Marini, PhD, David Harris, Zeev Estrov, MD, James McCubrey, PhD, W. Stratford May, MD, PhD, Marina Konopleva, MD, PhD

Blood (2005) 106 (11): 244.

https://doi.org/10.1182/blood.V106.11.244.244

Published: 2005

Journal Articles

Inhibition of Bcl-2 Signaling at Nanomolar Concentrations by Small Molecule BH3 Inhibitor, ABT-737 as a Novel Therapeutic Strategy in Acute Myeloid Leukemia (AML).

Rooha Contractor, Marina Konopleva, M.D., Ph.D., Xingming Deng, M.D., Ph.D., David Harris, Peter Ruvolo, Ph.D., Zeev Estrov, M.D., W. Stratford May, M.D., Ph.D., Saul H. Rosenberg, Ph.D., Michael Andreeff, M.D., Ph.D.

Blood (2004) 104 (11): 760.

https://doi.org/10.1182/blood.V104.11.760.760

Published: 2004

Journal Articles

Bcl2 retards G1/S cell cycle transition by regulating intracellular ROS

Xingming Deng, Fengqin Gao, W. Stratford May, Jr.

Blood (2003) 102 (9): 3179–3185.

https://doi.org/10.1182/blood-2003-04-1027

Published: 2003

Journal Articles

Cleavage of Bax to p18 Bax accelerates stress-induced apoptosis, and a cathepsin-like protease may rapidly degrade p18 Bax

Xuefang Cao, Xingming Deng, W. Stratford May

Blood (2003) 102 (7): 2605–2614.

https://doi.org/10.1182/blood-2003-01-0211

Published: 2003

NARROW

Small Molecule Bda-366 As a Bcl2-BH4 Antagonist for Multiple Myeloma Therapy

Protein phosphatase 2A inactivates Bcl2's antiapoptotic function by dephosphorylation and up-regulation of Bcl2-p53 binding

Protein Phosphatase 2A Inactivates Bcl2’s Antiapoptotic Function by Dephosphorylation and Up-Regulation of Bcl2-p53 Binding.

Bcl2 Flexible Loop Domain Positively and Negatively Regulates Survival Function through Direct Interaction with p53.

Mechanisms of Apoptosis Induction by BH3 Inhibitor ABT-737 in AML.

Inhibition of Bcl-2 Signaling at Nanomolar Concentrations by Small Molecule BH3 Inhibitor, ABT-737 as a Novel Therapeutic Strategy in Acute Myeloid Leukemia (AML).

Bcl2 retards G1/S cell cycle transition by regulating intracellular ROS

Cleavage of Bax to p18 Bax accelerates stress-induced apoptosis, and a cathepsin-like protease may rapidly degrade p18 Bax

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only